Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer.
about
Breast cancer subtypes predict the preferential site of distant metastases: a SEER based studyEvaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer.Prognostic value of Ki-67 in breast cancer patients with positive axillary lymph nodes: a retrospective cohort studyInference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis.Survival outcome and reduction rate of Ki-67 between pre- and post-neoadjuvant chemotherapy in breast cancer patients with non-pCR.FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.Neoadjuvant chemotherapy for different molecular breast cancer subtypes: a retrospective study in Russian population.Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer.A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients.Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy.Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients.Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response.Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy.
P2860
Q33709532-1AEA4ABD-6C64-4AB8-A5BE-381B2C10A868Q35145309-FF5FC170-9CB5-4AB6-BDA8-B23918A44085Q37548507-2F1134D6-5F38-43E7-B726-B1832CC07C6CQ37592617-F19349C4-7C6C-4CC3-BB89-27904F9C02B6Q38770344-97FA9917-46A6-495A-9207-4528E3B599C0Q45173811-1E1C6FF7-0B45-49B1-AB2B-68D10CEB6875Q45212093-8E3AC445-06DA-4AE4-84E0-26364F9CDA7FQ46542099-B3B6630D-3B9B-4E1E-A5A5-3AD1A63DF03AQ51018339-A73D6AD7-80B2-410A-93C0-9E7ECF5B7ACEQ51684386-F9CE426F-FD2F-48A9-943A-AFC0429CF1CCQ52680900-024B4868-5A1C-44D9-818F-CBDA26E28E4AQ52685576-BD79757D-8D66-4414-A95C-68A010EE2E85Q54187504-927F8F0C-8C59-4EA2-85F2-5E0CD47EA66BQ55273676-BD8B4D69-9D92-4EFD-8311-C7C7AD30F6CE
P2860
Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Different prognostic significa ...... ous subtypes of breast cancer.
@en
Different prognostic significa ...... ous subtypes of breast cancer.
@nl
type
label
Different prognostic significa ...... ous subtypes of breast cancer.
@en
Different prognostic significa ...... ous subtypes of breast cancer.
@nl
prefLabel
Different prognostic significa ...... ous subtypes of breast cancer.
@en
Different prognostic significa ...... ous subtypes of breast cancer.
@nl
P2093
P2860
P1476
Different prognostic significa ...... ous subtypes of breast cancer.
@en
P2093
Hirofumi Mukai
Nobuaki Matsubara
Noriaki Wada
Satoshi Fujii
P2860
P2888
P304
P356
10.1007/S10549-012-2344-6
P407
P577
2012-11-27T00:00:00Z
P6179
1048654975